Dr. Charles Diller Wendt, MD

  • Murfreesboro, TN
  • Radiation oncologist
NPI1144274416PAC ID9537145537
Medicare services, 2024
1,782
Medicare patients, 2024
223
Part D claims, 2024
576
MIPS score, 2024
93
Hospital affiliations
1
Practice address
509 E Bell St, Murfreesboro, TN 37130
Practice phone
Call (615) 329-0570
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Tennessee Oncology

Murfreesboro, Tennessee

See all 4 affiliations

Find Dr. Wendt's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Charles Diller Wendt is a radiation oncologist in Murfreesboro, Tennessee

Dr. Wendt practices at Tennessee Oncology in Murfreesboro, Tennessee.

Dr. Wendt's NPI, 1144274416, was assigned on May 20, 2006. Dr. Wendt graduated from Baylor College of Medicine in 1984. Dr. Wendt holds Tennessee license 20374.

NPI and contact details
Medicare PAC ID
9537145537
NPI enumeration date
May 20, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(615) 329-0570
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
68
Medical school graduation
1984

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Charles Diller Wendt practices at Tennessee Oncology in Murfreesboro, Tennessee

Dr. Wendt's primary practice is Tennessee Oncology, at 509 E Bell St, Murfreesboro, TN 37130 in Rutherford County. The practice phone is (615) 329-0570.

  • Tennessee Oncology
    509 E Bell St, Murfreesboro, TN 37130 · Rutherford CountyPhone(615) 329-0570

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Charles Diller Wendt is affiliated with 3 sites of care and 1 medical group

Dr. Wendt's primary practice is Tennessee Oncology in Murfreesboro, Tennessee. Dr. Wendt is also affiliated with Ascension Saint Thomas Rutherford. The medical group on file is Tennessee Oncology. Dmand AI also links Dr. Wendt to 1 more group practice or clinic, named with a free account.

See all 4 affiliations for Dr. Wendt

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Charles Diller Wendt's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wendt practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Tennessee OncologyAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Wendt practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Charles Diller Wendt is one of 120 radiation oncologists in Tennessee

Radiation oncology is Dr. Wendt's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Wendt is licensed in Tennessee.

Specialties and state licenses

  • Radiation oncology, TennesseePrimaryLicense 20374 · taxonomy 2085R0001X

Radiation oncologists near Dr. Wendt

Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.

120radiation oncologists in Tennessee
4radiation oncologists in Murfreesboro

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Charles Diller Wendt billed Medicare for 1,782 services in 2024

CMS data shows 1,782 Medicare services from Dr. Wendt across 19 procedure codes in 2024, for 223 Medicare patients. Medicare paid $113,418 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 20241,782
Medicare patients223
Paid by Medicare$113,418
Procedure codes19

Dr. Wendt's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Imaging
2023: 1,8162024: 1,52016%
Office and hospital visits
2023: 1582024: 1543%
Other services
2023: 1832024: 10841%

Dr. Wendt compared with the Tennessee median for radiation oncologists, 2024

  • Dr. Wendt
  • Tennessee median
Medicare services
1,782vs 1,738Close to median
Medicare patients
223vs 2116% above
Part D claims
477vs 568.5 times

Medians across 113 radiation oncologists in Tennessee with Dmand AI profiles that report each measure.

Dr. Wendt's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Wendt

Need commercial claims for Dr. Wendt?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Wendt and other radiation oncologists in Tennessee.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Charles Diller Wendt treated 223 Medicare patients in 2024, average age 74

CMS counts 223 Medicare patients who saw Dr. Wendt in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have cancer, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wendt's median patient age at 70, with 47% women.

Medicare patients, 2024223
Average age74
Average risk score1.65
Also on Medicaid10%

Dr. Wendt's Medicare patients by age, 2024

Dr. Wendt's Medicare patients by sex, 2024

  • Women10045%
  • Men12355%

Chronic conditions among Dr. Wendt's Medicare patients, 2024

  1. Cancer75%
  2. High blood pressure75%
  3. High cholesterol75%
  4. Arthritis48%
  5. Diabetes33%
  6. Ischemic heart disease32%
  7. Chronic kidney disease29%
  8. COPD28%

Share of Medicare patients with each condition. A patient can have several.

Dr. Wendt's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 70

Patient panel by sex, all payers

  • Women47%
  • Men52%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Charles Diller Wendt wrote 576 Medicare Part D claims in 2024

In 2024, Dr. Wendt wrote 576 Medicare Part D claims for 172 patients. 95% of them were for generic drugs. CMS names the drug for 477 of them, across 16 drugs with 11 or more claims each, at $6,003 in total drug cost. In 2023, CMS named 483 claims across 16 drugs.

Part D claims, 2024576
Drugs named by CMS16
Total drug cost$6,003
Part D patients172

Dr. Wendt's Part D claims by kind of drug, 2024

  • Generic549 claims95%
  • Brand-name15 claims3%
  • Other12 claims2%

Dr. Wendt's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Wendt's Part D claims, 2024

  • Opioids13%72 of 576 claims
  • Antibiotics7%40 of 576 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 4832024: 4771%

Drugs named by CMS: 16 in 2024, 16 in 2023.

See all prescribing by Dr. Wendt

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Charles Diller Wendt scored 93 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Wendt for performance year 2024, reported as part of a group. Dr. Wendt accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Wendt's MIPS scores, performance year 2024

  • 93of 100Final score
  • 89of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find radiation oncologists like Dr. Wendt by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Charles Diller Wendt received $327 in industry payments from 2018 to 2025

CMS Open Payments shows 5 general payments to Dr. Wendt from 4 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $185.

General payments to Dr. Wendt by program year, 2018 to 2025

Companies that paid Dr. Wendt the most, 2018 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Wendt

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Charles Diller Wendt graduated from Baylor College of Medicine

Dr. Wendt graduated from Baylor College of Medicine in 1984.

  1. Medical schoolBaylor College of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Charles Diller Wendt's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Charles Diller Wendt

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Charles Diller Wendt's NPI number?

Dr. Charles Diller Wendt's NPI number is 1144274416. It was assigned on May 20, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Charles Diller Wendt?

Dr. Charles Diller Wendt is a radiation oncologist in Murfreesboro, Tennessee. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).

Where does Dr. Charles Diller Wendt practice?

Dr. Wendt practices at 509 E Bell St, Murfreesboro, TN 37130. Dr. Wendt's primary practice is Tennessee Oncology in Murfreesboro, Tennessee. Dmand AI also links Dr. Wendt to 1 group practice or clinic.

What is Dr. Charles Diller Wendt's office phone number?

The practice phone on file for Dr. Wendt is (615) 329-0570.

What is Dr. Charles Diller Wendt's medical license number?

Dr. Wendt holds Tennessee license 20374.

Which hospitals is Dr. Charles Diller Wendt affiliated with?

Dr. Wendt is affiliated with Ascension Saint Thomas Rutherford.

What medical group is Dr. Charles Diller Wendt part of?

Dr. Wendt is linked to Tennessee Oncology.

Does Dr. Charles Diller Wendt accept Medicare?

Yes. CMS data shows Dr. Wendt billed Medicare for 1,782 services in 2024, and Dr. Wendt accepts Medicare assignment.

What is Dr. Charles Diller Wendt's MIPS score?

Dr. Wendt's MIPS final score for performance year 2024 is 93 out of 100, reported as part of a group.

How many Medicare patients does Dr. Charles Diller Wendt see?

CMS counts 223 Medicare patients who saw Dr. Wendt in 2024, with an average age of 74.

Show 5 more questionsShow fewer questions

What services does Dr. Charles Diller Wendt bill to Medicare?

In 2024, Dr. Wendt's most billed Medicare services were radiation oncology (77014), radiation oncology (77300) and radiation oncology (77427).

Where did Dr. Charles Diller Wendt go to medical school?

Dr. Wendt graduated from Baylor College of Medicine in 1984.

What drugs does Dr. Charles Diller Wendt prescribe most?

In 2024 Medicare Part D data, Dr. Wendt's most prescribed drugs by claims were Diphenoxylate-Atropine, Tamsulosin HCl and Triamcinolone Acetonide.

Has Dr. Charles Diller Wendt received payments from drug or device companies?

CMS Open Payments shows $327 in general payments to Dr. Wendt from 4 companies from 2018 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Charles Diller Wendt been practicing?

Dr. Wendt graduated from medical school in 1984, 42 years ago.

Selling to radiation oncology practices?

See radiation oncologists in Tennessee by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)